Overview

Emergence Times and Airway Reactions in General Laryngeal Mask Airway Anesthesia

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is first to assess if desflurane is superior in order to achieve a faster emergence from anesthesia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
RWTH Aachen University
Treatments:
Anesthetics
Desflurane
Isoflurane
Propofol
Sevoflurane
Criteria
Inclusion Criteria:

- Planned anesthesia with use of LMA (laryngeal mask airway)

- Planned duration of anesthesia between 0.5 and 2 hours

- Age between 18-75 years

- Both gender

- Body mass index (BMI) <35

- ASA 1-3

- Written informed consent prior to study participation

Exclusion Criteria:

- Planned additional regional and local anesthesia

- Contra-indication for the use of a laryngeal mask airway

- Asthma

- COPD IV

- Known allergy or hypersensitivity to any drugs administered during this study

- Women who are pregnant, breast-feeding or women of childbearing potential not using
adequate contraceptive methods

- Participation in a drug or device trial within the previous 30 days.

- Patients legally unable to give written informed consent.

- Patients with severe psychiatric disorders

- Recent (<6 months) history of alcohol or drug abuse

- Patients with severe neuropsychiatric disorders

- Non-fluency in German language